Price target
146.090.000.00%
The 26 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 29 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
1NBIX EPS for the last quarter is 0.90 EUR despite the estimation of 0.82 EUR. In the next quarter EPS is expected to reach 1.35 EUR. Track more of Neurocrine Biosciences, Inc. financials and stay on top of what is up with the company.
In the next quarter Neurocrine Biosciences, Inc. revenue is expected to reach 637.97 M EUR. Check out Neurocrine Biosciences, Inc. revenue and earnings and make informed decisions.
According to analysts, 1NBIX price target is 146.09 EUR with a max estimate of 172.31 EUR and a min estimate of 106.83 EUR. Check if this forecast comes true in a year, meanwhile watch Neurocrine Biosciences, Inc. stock price chart and keep track of the current situation with 1NBIX news and stock market news.
We've gathered opinions of 29 analysts rating 1NBIX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.